Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like Value of digital transactions rose marginally in May, RBI data shows June 7, 2017 FlexArm introduces GH-60 tapping arm November 13, 2018 LabVIEW announces enhanced version of LabVIEW NXG engineering system design software January 23, 2018
LabVIEW announces enhanced version of LabVIEW NXG engineering system design software January 23, 2018